Key result
Elevated resting heart rate (71-76 bpm) was associated with a 1.84-times higher likelihood of disease-free survival events compared to ≤70 bpm (p=0.016).
Why the study?
Although resting heart rate is associated with mortality in cancers like breast, colorectal, and lung cancer, its association with oncological outcomes in early-stage cervical cancer remained unexplored.
Does resting heart rate predict oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy?
Cohort (n=622)
Does resting heart rate predict oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy?
Hazard Ratio: 1.84
p-value: p=0.016
Higher resting heart rate is an independent prognostic factor for worse disease-free and overall survival in patients with early-stage cervical cancer undergoing radical surgery.
May refine post-hysterectomy risk stratification; hypothesis-generating for RHR modification trials in early cervical cancer.
INTRODUCTION: A few studies have explored the association of resting heart rate (RHR) with mortality and/or other oncological outcomes in patients with specific cancers such as breast, colorectal, and lung cancer. This study aimed to evaluate the association between the RHR and oncological outcomes in patients with early-stage cervical cancer (CC) who underwent radical surgical resection. METHODS: We included 622 patients with early-stage CC (stages IA2-IB1). The patients were divided into four groups based on the RHR as follows: quartile 1, ≤64; quartile 2, 65-70; quartile 3, 71-76; and quartile 4, >76 beats per min (bpm), with the lowest quartile being the reference group. We evaluated the associations of the RHR and clinicopathological features with oncological outcomes using Cox proportional-hazards regression. RESULTS: There were clear among-group differences. Further, there was a significant positive correlation of RHR with tumor size and deep stromal invasion. Multivariate analysis revealed that RHR was an independent prognostic factor for disease-free survival (DFS) and overall survival (OS). Compared with patients with an RHR ≤70 bpm, those with an RHR of 71-76 bpm had a 1.84- and 3.05-times higher likelihood of DFS (p = 0.016) and OS (p = 0.030), respectively, while those with RHR >76 bpm had a 2.20-times higher likelihood of DFS (p = 0.016). CONCLUSION: This is the first study to demonstrate that RHR may be an independent prognostic factor for oncological outcomes in patients with CC.
No takes yet. Share an insight, caveat, or question.
Dhanaworavibul et al. (2023) conducted a cohort in Early-stage cervical cancer (n=622). Resting heart rate (RHR) vs. RHR ≤70 bpm was evaluated on Disease-free survival (DFS) (HR 1.84, p=0.016). Elevated resting heart rate (71-76 bpm) was associated with a 1.84-times higher likelihood of disease-free survival events compared to ≤70 bpm (p=0.016).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: